Choices in medical management for prevention of acute ischemic stroke.

James Fleck, J. Biller

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Stroke is a leading cause of death and disability. Although advances are being made in the treatment of acute ischemic stroke, its prevention is equally as important. Identification and management of risk factors are essential. Medical therapy is also helpful in the secondary prevention of ischemic stroke. There are currently four platelet-antiaggregating agents used to prevent ischemic stroke: aspirin, aspirin plus dipyridamole, clopidogrel, and ticlopidine. The relevant studies proving their efficacy are noted, as are some of their similarities and differences. The use of warfarin is also discussed.

Original languageEnglish
Pages (from-to)33-38
Number of pages6
JournalCurrent Neurology and Neuroscience Reports
Volume1
Issue number1
StatePublished - Jan 2001

Fingerprint

Stroke
clopidogrel
Aspirin
Ticlopidine
Dipyridamole
Warfarin
Secondary Prevention
Cause of Death
Blood Platelets
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Choices in medical management for prevention of acute ischemic stroke. / Fleck, James; Biller, J.

In: Current Neurology and Neuroscience Reports, Vol. 1, No. 1, 01.2001, p. 33-38.

Research output: Contribution to journalArticle

@article{654f8c44b790476295fdafc32d08ab6a,
title = "Choices in medical management for prevention of acute ischemic stroke.",
abstract = "Stroke is a leading cause of death and disability. Although advances are being made in the treatment of acute ischemic stroke, its prevention is equally as important. Identification and management of risk factors are essential. Medical therapy is also helpful in the secondary prevention of ischemic stroke. There are currently four platelet-antiaggregating agents used to prevent ischemic stroke: aspirin, aspirin plus dipyridamole, clopidogrel, and ticlopidine. The relevant studies proving their efficacy are noted, as are some of their similarities and differences. The use of warfarin is also discussed.",
author = "James Fleck and J. Biller",
year = "2001",
month = "1",
language = "English",
volume = "1",
pages = "33--38",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Choices in medical management for prevention of acute ischemic stroke.

AU - Fleck, James

AU - Biller, J.

PY - 2001/1

Y1 - 2001/1

N2 - Stroke is a leading cause of death and disability. Although advances are being made in the treatment of acute ischemic stroke, its prevention is equally as important. Identification and management of risk factors are essential. Medical therapy is also helpful in the secondary prevention of ischemic stroke. There are currently four platelet-antiaggregating agents used to prevent ischemic stroke: aspirin, aspirin plus dipyridamole, clopidogrel, and ticlopidine. The relevant studies proving their efficacy are noted, as are some of their similarities and differences. The use of warfarin is also discussed.

AB - Stroke is a leading cause of death and disability. Although advances are being made in the treatment of acute ischemic stroke, its prevention is equally as important. Identification and management of risk factors are essential. Medical therapy is also helpful in the secondary prevention of ischemic stroke. There are currently four platelet-antiaggregating agents used to prevent ischemic stroke: aspirin, aspirin plus dipyridamole, clopidogrel, and ticlopidine. The relevant studies proving their efficacy are noted, as are some of their similarities and differences. The use of warfarin is also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0035240043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035240043&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 33

EP - 38

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 1

ER -